Enantioselective formation of tertiary and quaternary allylic C-N bonds via allylation of tetrazoles.

Chem Commun (Camb)

Institut für Organische Chemie, Albert-Ludwigs-Universität Freiburg, Albertstrasse 21, 79104 Freiburg, Germany.

Published: July 2015

Rhodium-catalyzed regio- and enantioselective coupling of tetrazoles with allenes are reported. Asymmetric construction of tertiary and quaternary allylic C-N bonds were achieved using a Rh(I)/JoSPOphos catalyst. This method permits the atom-economic synthesis of various valuable N(2)-allylic tetrazoles.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5cc04203hDOI Listing

Publication Analysis

Top Keywords

tertiary quaternary
8
quaternary allylic
8
allylic c-n
8
c-n bonds
8
enantioselective formation
4
formation tertiary
4
bonds allylation
4
allylation tetrazoles
4
tetrazoles rhodium-catalyzed
4
rhodium-catalyzed regio-
4

Similar Publications

Design of a light and Ca switchable organic-peptide hybrid.

Proc Natl Acad Sci U S A

February 2025

SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon 16419, Republic of Korea.

The design of organic-peptide hybrids has the potential to combine our vast knowledge of protein design with small molecule engineering to create hybrid structures with complex functions. Here, we describe the computational design of a photoswitchable Ca-binding organic-peptide hybrid. The designed molecule, designated Ca-binding switch (CaBS), combines an EF-hand motif from classical Ca-binding proteins such as calmodulin with a photoswitchable group that can be reversibly isomerized between a spiropyran (SP) and merocyanine (MC) state in response to different wavelengths of light.

View Article and Find Full Text PDF

Human Kv1.3, encoded by , is expressed in neuronal and immune cells. Its impaired expression or function produces chronic inflammatory disease and autoimmune disorders, the severity of which correlates with Kv1.

View Article and Find Full Text PDF

Atomistic Insights Into Interaction of Doxorubicin With DNA: From Duplex to Nucleosome.

J Comput Chem

January 2025

Regional Center of Advanced Technologies and Materials, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, Olomouc, Czech Republic.

Doxorubicin (DOX) is a widely used chemotherapeutic agent known for intercalating into DNA. However, the exact modes of DOX interactions with various DNA structures remain unclear. Using molecular dynamics (MD) simulations, we explored DOX interactions with DNA duplexes (dsDNA), G-quadruplex, and nucleosome.

View Article and Find Full Text PDF

Reactions of Tertiary Aliphatic Cations with Silylated Alkynes: Substitution, Cyclization and Unexpected C-H Activation Products.

Chemistry

January 2025

Université de Rennes 1, Chemistry, Equipe CORINT, Institut des Sciences Chimiques de Rennes, Université de Rennes 1 - UMR 6226 CNRS, Bâtiment 10A, Bureau 158, Avenue du Général Leclerc, 35042, Rennes, FRANCE.

Capozzi's groundbreaking work in 1982 introduced a fascinating reaction involving highly reactive tertiary aliphatic cations and silylated alkynes. This reaction provided an innovative solution to the challenge of coupling a fully substituted tertiary aliphatic fragment with an alkyne moiety. Building upon Capozzi's pioneering efforts, we started an extensive exploration of reaction conditions to expand the initial scope of this reaction.

View Article and Find Full Text PDF

This study investigated the applicability of a protein-like fluorescence sensor for wastewater quality monitoring. Several wastewater matrices, including raw, primary, secondary and tertiary effluents from three different wastewater treatment plants were used. Furthermore, the sensor was tested for the monitoring of quaternary effluent in a pilot scale plant installed downstream of a water reuse facility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!